Katsuya Suzuki Selected Research

Antirheumatic Agents (DMARD)

1/2023	Changes in the molecular profiles of large-vessel vasculitis treated with biological disease-modifying anti-rheumatic drugs and Janus kinase inhibitors.
1/2021	Molecular remission at T cell level in patients with rheumatoid arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katsuya Suzuki Research Topics

Disease

23	Rheumatoid Arthritis 07/2023 - 01/2006
9	Immunoglobulin G4-Related Disease 01/2023 - 09/2015
9	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2016
8	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2024 - 09/2003
6	Inflammation (Inflammations) 10/2021 - 02/2009
4	Vasculitis (Vasculitides) 01/2023 - 01/2021
3	Arthritis (Polyarthritis) 03/2024 - 06/2011
3	Polyps 06/2023 - 01/2022
3	COVID-19 12/2022 - 01/2021
3	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2020
3	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2021 - 01/2021
3	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2021 - 01/2020
3	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 10/2019 - 01/2018
3	Body Weight (Weight, Body) 01/2018 - 06/2015
3	Rheumatic Diseases (Rheumatism) 06/2016 - 01/2009
2	Cognitive Dysfunction 10/2023 - 01/2020
2	Pathologic Constriction (Stenosis) 04/2023 - 01/2016
2	Lymphadenopathy 01/2021 - 01/2016
2	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2021 - 01/2020
2	Mixed Connective Tissue Disease (MCTD) 01/2021 - 02/2015
2	Systemic Scleroderma (Systemic Sclerosis) 01/2021 - 01/2020
2	Synovitis 10/2019 - 02/2016
2	Sialadenitis 04/2016 - 09/2010
2	Obesity 01/2016 - 01/2011
2	Atherosclerosis 11/2009 - 07/2006
1	Arteritis 04/2024
1	Coronary Vasospasm (Coronary Artery Vasospasm) 04/2024
1	Sinus Histiocytosis (Rosai-Dorfman Disease) 03/2024
1	Anemia 01/2024
1	Myocarditis (Carditis) 12/2023
1	Wounds and Injuries (Trauma) 12/2023
1	Infections 06/2023
1	Atrial Fibrillation 05/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2023
1	Iron Deficiencies 01/2023

Drug/Important Bio-Agent (IBA)

9	Immunoglobulin G (IgG)IBA 01/2023 - 09/2015
8	GlucocorticoidsIBA 01/2021 - 01/2009
7	tocilizumab (atlizumab)FDA Link 07/2023 - 10/2015
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2015
6	Methotrexate (Mexate)FDA LinkGeneric 03/2024 - 06/2016
6	Infliximab (Remicade)FDA Link 03/2024 - 01/2006
6	Messenger RNA (mRNA)IBA 01/2024 - 09/2003
6	Proteins (Proteins, Gene)FDA Link 10/2021 - 05/2005
5	AntibodiesIBA 01/2024 - 01/2020
5	Amino Acids FDA Link 10/2023 - 01/2016
5	Interleukin-6 (Interleukin 6)IBA 07/2023 - 05/2015
5	InterleukinsIBA 01/2022 - 07/2018
5	Essential Amino AcidsIBA 01/2022 - 06/2015
5	C-Reactive ProteinIBA 01/2021 - 09/2009
4	Adalimumab (Humira)FDA Link 01/2019 - 09/2016
4	Serotonin (5 Hydroxytryptamine)IBA 11/2010 - 07/2006
3	PolyphosphatesIBA 06/2023 - 01/2022
3	DAPIIBA 06/2023 - 01/2022
3	Neutralizing AntibodiesIBA 12/2022 - 01/2021
3	AutoantibodiesIBA 01/2021 - 02/2015
3	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021 - 01/2020
3	CytokinesIBA 10/2019 - 10/2015
3	Leucine (L-Leucine)FDA Link 01/2016 - 05/2015
2	Serine (L-Serine)FDA Link 10/2023 - 01/2020
2	Antirheumatic Agents (DMARD)IBA 01/2023 - 01/2021
2	NAD (NADH)IBA 09/2022 - 01/2022
2	Adenosine Triphosphate (ATP)IBA 09/2022 - 01/2022
2	Prednisolone (Predate)FDA LinkGeneric 07/2021 - 01/2009
2	Rituximab (Mabthera)FDA Link 07/2021 - 01/2018
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2020 - 10/2017
2	Interleukin-10 (Interleukin 10)IBA 10/2019 - 02/2017
2	Interleukin-2 Receptors (IL 2 Receptor)IBA 10/2019 - 05/2018
2	Tumor Necrosis Factor InhibitorsIBA 01/2019 - 01/2016
2	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2016 - 06/2011
2	Glycoproteins (Glycoprotein)IBA 01/2016 - 05/2015
2	Muscle Proteins (Muscle Protein)IBA 01/2016 - 06/2015
2	Interleukin-4 (Interleukin 4)IBA 09/2015 - 09/2010
2	Tacrolimus (Prograf)FDA LinkGeneric 06/2011 - 02/2009
2	PolyphenolsIBA 11/2010 - 11/2009
2	N-(p-coumaroyl)serotoninIBA 11/2010 - 11/2009
2	oxidized low density lipoproteinIBA 11/2010 - 07/2006
2	N-feruloylserotoninIBA 11/2010 - 11/2009
2	LDL Lipoproteins (beta Lipoproteins)IBA 11/2010 - 07/2006
2	3' Untranslated Regions (3' UTR)IBA 03/2008 - 01/2006
2	zeta chain antigen T cell receptor (TCR zeta chain)IBA 03/2005 - 09/2003
2	T-Cell Antigen Receptor-CD3 ComplexIBA 03/2005 - 09/2003
1	Acetylcholine (Acetylcholine Chloride)FDA Link 04/2024
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2024
1	Immune Checkpoint InhibitorsIBA 12/2023
1	Proline (L-Proline)FDA Link 10/2023
1	Cystine (L-Cystine)IBA 10/2023
1	ORALIT (ORS)IBA 10/2023
1	sarilumabIBA 07/2023
1	SuspensionsIBA 06/2023
1	Antiviral Agents (Antivirals)IBA 06/2023
1	Brain Natriuretic Peptide (Natrecor)FDA Link 05/2023
1	Indicators and Reagents (Reagents)IBA 05/2023
1	omega-Chloroacetophenone (Mace)IBA 02/2023
1	Janus Kinase InhibitorsIBA 01/2023
1	IronIBA 01/2023
1	InterferonsIBA 01/2022

Therapy/Procedure

8	Therapeutics 12/2023 - 09/2009
3	Catheter Ablation 05/2023 - 02/2013
2	Aftercare (After-Treatment) 05/2018 - 05/2015
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 04/2023